Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing

NCT02998112 Phase 4 UNKNOWN

To indicate the efficacy of Fecal microbiota transplantation (FMT) for the treatment of Ulcerative colitis (UC), The investigators design a multicenter, randomized controlled trial to perform FMT through colonic transendoscopic enteral tubing (TET) way, and evaluate the efficacy and safety of FMT for patients with moderate or severe UC.

Details

Lead sponsor	The Second Hospital of Nanjing Medical University
Phase	Phase 4
Status	UNKNOWN
Enrolment	188
Start date	2016-12
Completion	2017-12

Conditions

• Ulcerative Colitis

Interventions

• fecal microbiota transplantation
• Saline

Primary outcomes

• Clinical remission — 12 weeks
  Total Mayo score less than 2 and no signal item more than 1
• Clinical improvement — 12 weeks
  Total Mayo score decreased more than 3 or decreased more than 30%

Countries

China